Filing Flows › Glaukos (GKOS) › Q1 2026
Glaukos (GKOS) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 30, 2026
Glaukos (GKOS) reported revenue of $151M for the first quarter 2026 (Q1 2026), +41% from a year earlier and +5% from the quarter before. Operating margin was -13.2%, net loss $19.8M (13.1% of revenue).
Glaukos, Q1 2026: revenue $151M (+41% year over year), operating margin -13.2%, net loss $19.8M, operating cash flow −$12.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $151M | +5% | +41% |
| Operating profit | −$19.9M | — | — |
| Net earnings | −$19.8M | — | — |
| Operating cash flow | −$12.5M | -283% | — |
What changed
Revenue was $150.6M in Q1 2026, up 41% year over year and up 5% from the previous quarter. Glaucoma was the largest line at 86% of revenue. Glaucoma added $41.1M year over year (up 47%), 94% of the total change.
Gross margin was 77.9%, up 0.7 points from Q1 2025. Operating costs exceeded revenue by $19.9M, an operating margin of -13.2%. Operating expenses grew 33% against revenue growth of 41%. The fastest-growing cost line was Research & development (+36%). The quarter ended with a net loss of $19.8M, narrower than the previous quarter's $133.7M loss.
Operating cash flow was −$12.5M. Non-cash charges added back $11.8M of depreciation and amortization and $19.1M of share-based compensation. Working capital and other items used $23.7M. Capital expenditures of $4.0M exceeded it, leaving free cash flow of −$16.5M.
Questions
What was Glaukos' revenue in the first quarter 2026?
Glaukos (GKOS) reported revenue of $151M for the first quarter 2026 (Q1 2026), +41% from a year earlier and +5% from the quarter before.
Was Glaukos profitable in the first quarter 2026?
Operating loss was $19.9M (-13.2% of revenue) and net loss $19.8M.
Source: Glaukos 10-Q on SEC EDGAR.